146 related articles for article (PubMed ID: 7615649)
1. Post-translational abnormality of the type II cyclic AMP-dependent protein kinase in psoriasis: modulation by retinoic acid.
Tournier S; Gerbaud P; Anderson WB; Lohmann SM; Evain-Brion D; Raynaud F
J Cell Biochem; 1995 Apr; 57(4):647-54. PubMed ID: 7615649
[TBL] [Abstract][Full Text] [Related]
2. Retinoylation of the type II cAMP-binding regulatory subunit of cAMP-dependent protein kinase is increased in psoriatic human fibroblasts.
Tournier S; Raynaud F; Gerbaud P; Lohmann SM; Anderson WB; Evain-Brion D
J Cell Physiol; 1996 May; 167(2):196-203. PubMed ID: 8613459
[TBL] [Abstract][Full Text] [Related]
3. Patterns of cyclic AMP-dependent protein kinase gene expression during ontogeny of the murine palate.
Greene RM; Lloyd MR; Uberti M; Nugent P; Pisano MM
J Cell Physiol; 1995 Jun; 163(3):431-40. PubMed ID: 7775586
[TBL] [Abstract][Full Text] [Related]
4. Oxidative modulation of cyclic AMP-dependent protein kinase in human fibroblasts: possible role in psoriasis.
Raynaud F; Evain-Brion D; Gerbaud P; Marciano D; Gorin I; Liapi C; Anderson WB
Free Radic Biol Med; 1997; 22(4):623-32. PubMed ID: 9013125
[TBL] [Abstract][Full Text] [Related]
5. Cyclic AMP-dependent protein kinase (cAK) in human B cells: co-localization of type I cAK (RI alpha 2 C2) with the antigen receptor during anti-immunoglobulin-induced B cell activation.
Levy FO; Rasmussen AM; Taskén K; Skålhegg BS; Huitfeldt HS; Funderud S; Smeland EB; Hansson V
Eur J Immunol; 1996 Jun; 26(6):1290-6. PubMed ID: 8647207
[TBL] [Abstract][Full Text] [Related]
6. Retinoic acid effect on cyclic AMP-dependent protein kinases in embryonal carcinoma cells: studies with differentiation-defective sublines.
Plet A; Gerbaud P; Sherman MI; Anderson WB; Brion DE
J Cell Physiol; 1986 May; 127(2):341-7. PubMed ID: 3700486
[TBL] [Abstract][Full Text] [Related]
7. Regulation of the laminin beta 1 (LAMB1), retinoic acid receptor beta, and bone morphogenetic protein 2 genes in mutant F9 teratocarcinoma cell lines partially deficient in cyclic AMP-dependent protein kinase activity.
Shen J; Li C; Gudas LJ
Cell Growth Differ; 1997 Dec; 8(12):1297-304. PubMed ID: 9419418
[TBL] [Abstract][Full Text] [Related]
8. A nuclear cAMP binding protein in retinoic acid-treated HL-60 cells.
Briggs RC; Casey SB
J Cell Physiol; 1988 Jul; 136(1):198-201. PubMed ID: 2840443
[TBL] [Abstract][Full Text] [Related]
9. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
[TBL] [Abstract][Full Text] [Related]
10. Purification of a regulatory subunit of type II cAMP-dependent protein kinase from Drosophila heads.
Inoue H; Yoshioka T
Biochem Biophys Res Commun; 1997 Jun; 235(1):223-6. PubMed ID: 9196067
[TBL] [Abstract][Full Text] [Related]
11. Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.
Liapi C; Takahashi N; Raynaud F; Evain-Brion D; Anderson WB
J Invest Dermatol; 1998 Apr; 110(4):332-7. PubMed ID: 9540970
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of regulatory subunit of type I cyclic AMP-dependent protein kinase: biphasic effects of cyclic AMP in intact S49 mouse lymphoma cells.
Russell JL; Steinberg RA
J Cell Physiol; 1987 Feb; 130(2):207-13. PubMed ID: 3029147
[TBL] [Abstract][Full Text] [Related]
13. Compartmentation of the type I regulatory subunit of cAMP-dependent protein kinase in cardiac ventricular muscle.
Reinitz CA; Bianco RA; Shabb JB
Arch Biochem Biophys; 1997 Dec; 348(2):391-402. PubMed ID: 9434753
[TBL] [Abstract][Full Text] [Related]
14. Cyclic adenosine 3':5'-monophosphate-dependent protein kinase on the external surface of LS-174T human colon carcinoma cells.
Kondrashin A; Nesterova M; Cho-Chung YS
Biochemistry; 1999 Jan; 38(1):172-9. PubMed ID: 9890895
[TBL] [Abstract][Full Text] [Related]
15. Functional changes in the regulatory subunit of the type II cyclic adenosine 3':5'-monophosphate-dependent protein kinase isozyme during normal and neoplastic lung development.
Butley MS; Beer DG; Malkinson AM
Cancer Res; 1984 Jun; 44(6):2689-97. PubMed ID: 6327022
[TBL] [Abstract][Full Text] [Related]
16. Effect of phorbol ester on cyclic adenosine 3':5'-monophosphate-dependent protein kinases in PYS teratocarcinoma-derived cells and counteraction with retinoic acid.
Plet A; Gerbaud P; Anderson WB; Evain-Brion D
Cancer Res; 1988 Jul; 48(14):3993-7. PubMed ID: 2838167
[TBL] [Abstract][Full Text] [Related]
17. Modulation of the activity of calpain II by phosphorylation--changes in the proteolysis of cyclic AMP-dependent protein kinase (peak II, DEAE).
Kuo WN; Ganesan U; Walbey DL; Davis DL; Allen K; McCall LK
Appl Theor Electrophor; 1993; 3(6):317-20. PubMed ID: 8199224
[TBL] [Abstract][Full Text] [Related]
18. Cyclic AMP-dependent protein kinases from Balb 3T3 cells and other 3T3 derived lines.
Wehner JM; Malkinson AM; Wiser MF; Sheppard JR
J Cell Physiol; 1981 Aug; 108(2):175-84. PubMed ID: 6267082
[TBL] [Abstract][Full Text] [Related]
19. B16 mouse melanoma cells selected for resistance to cyclic AMP-mediated growth inhibition are cross-resistant to retinoic acid-induced growth inhibition.
Niles RM; Loewy B
J Cell Physiol; 1991 Apr; 147(1):176-81. PubMed ID: 1645360
[TBL] [Abstract][Full Text] [Related]
20. Regulation, localization, and anchoring of protein kinase A subunits during mouse sperm capacitation.
Visconti PE; Johnson LR; Oyaski M; Fornés M; Moss SB; Gerton GL; Kopf GS
Dev Biol; 1997 Dec; 192(2):351-63. PubMed ID: 9441673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
